New lessons for an old problem: ASSET open-label extension

被引：0
|
作者：
Del Galdo, Francesco [1 ,2 ]
机构：
[1] Univ Leeds, Inst Rheumat & Musculoskeletal Med, Scleroderma Programme, Leeds LS7 4SA, W Yorkshire, England
[2] Natl Inst Hlth, Res Biomed Res Ctr, Leeds, W Yorkshire, England
来源：
LANCET RHEUMATOLOGY | 2020年 / 2卷 / 12期
关键词：
ABATACEPT; EFFICACY; SAFETY; CTLA4;
D O I：
10.1016/S2665-9913(20)30379-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E726 / E727
页数：2
相关论文
共 50 条
  • [1] Open-label extension studies and misinformation
    Schneider, Lon S.
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (07) : 1036 - 1036
  • [2] What are open-label extension studies for?
    Taylor, WJ
    Weatherall, M
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (04) : 642 - 643
  • [3] PERAMPANEL AS MONOTHERAPY IN OPEN-LABEL EXTENSION STUDIES
    Kwan, Patrick
    Mintzer, Scott
    Laurenza, Antonio
    Patten, Anna
    Cartwright, Karen
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A23 - A23
  • [4] Open-Label Extension Studies: Are They Really Research?
    Cho, Mildred K.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2014, 14 (03): : 1 - 2
  • [5] Open-Label Extension Studies: Are They Really Research?
    Cho, Mildred K.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2014, 14 (04): : 60 - 61
  • [6] Open-Label Extension StudiesDo They Provide Meaningful Information on the Safety of New Drugs?
    Richard O. Day
    Kenneth M. Williams
    [J]. Drug Safety, 2007, 30 : 93 - 105
  • [7] PASADENA 1-year Open-label Extension
    Pagano, G.
    Reyes, A.
    Monnet, A.
    Martinec, M.
    Shariati, N.
    Simuni, T.
    Marek, K.
    Postuma, R.
    Pavese, N.
    Stocchi, F.
    Taylor, K.
    Svoboda, H.
    Fontoura, P.
    Kerchner, G.
    Doody, R.
    Bonni, A.
    Nikolcheva, T.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S44 - S44
  • [8] Open-label extension studies: Interpretation and statistical issues
    Weatherall M.
    Burgess C.
    Taylor W.
    [J]. International Journal of Pharmaceutical Medicine, 2007, 21 (2) : 115 - 120
  • [9] When Should Open-Label Extension Studies Be Stopped?
    Crites, Joshua S.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2014, 14 (04): : 57 - 58
  • [10] Open-label extension studies - Do they provide meaningful information on the safety of new drugs?
    Day, Richard O.
    Williams, Kenneth M.
    [J]. DRUG SAFETY, 2007, 30 (02) : 93 - 105
12345